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a b s t r a c t
Background: Although regarded as rare in the United States (US), increased global trafﬁc and
importation of malaria from endemic countries may lead to a rise in gestational malaria in
the US.
Methods: This multi-year retrospective study analyzed trends in diagnosed cases of gestational
malaria from 2002 to 2017 using joinpoint regression models. We also assessed the association
between gestational malaria and selected maternal-fetal adverse outcomes.
Results: Mothers diagnosed with gestational malaria tended to be older, and the majority of diagnosed cases (52.9%) were among Non-Hispanic (NH) Blacks. Diagnosed cases of gestational
malaria are on the rise in the US. Mothers diagnosed with gestational malaria were 5 times
as likely (OR = 5.05, 95% CI: 4.05–6.29) to be anemic as compared to those without malaria.
Compared to NH-Whites, NH-Black mothers were twice as likely to experience stillbirth, had
nearly 50% greater adjusted odds of severe preeclampsia, and had about 30% elevated likelihood for preterm labor.
Conclusions: There is a need to dedicate appropriate resources to identify women that are at
risk for gestational malaria in order to prevent related pregnancy complications.
© 2020 The Authors. Published by Elsevier Ltd on behalf of World Federation of Parasitologists.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).

1. Introduction
Malaria is a parasitic infection that accounts for a considerable level of morbidity and mortality worldwide (Tsuji and Kain,
2009). Human transmission of malaria occurs through the bloodstream by the protozoan parasite, Plasmodium. Of the ﬁve Plasmodium species that infect humans, P. falciparum is associated with poorer clinical outcomes and P. vivax comprises the majority of
case (Geleta and Ketema, 2016; Howes et al., 2016). Major complications of malaria include severe anemia, respiratory distress,
renal failure, and death (White, 2018). Approximately 3.2 billion people live in endemic regions such as sub-Saharan Africa,
which accounts for over 90% of malaria-related cases and deaths (Odhiambo and Sartorius, 2018; World Health Organization,
2020). Health initiatives such as antimalarial therapies, insecticide-treated nets, and indoor residual spraying have greatly reduced
the global burden of malaria (Kenangalem et al., 2019; Centers for Disease Control and Prevention, 2019a; Choi et al., 2019). Yet,
in 2018 alone, there were approximately 228 million cases of malaria and 405,000 malaria-related deaths globally (World Health
Organization, 2020).
⁎ Corresponding author at: Center of Excellence in Health Equity, Training, and Research, Baylor College of Medicine, 3701 Kirby Drive, Houston, TX 77098, USA.
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2405-6731/© 2020 The Authors. Published by Elsevier Ltd on behalf of World Federation of Parasitologists. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Pregnancy-associated immune-related changes in pregnancy places expectant mothers at an increased risk of contracting malaria (World Health Organization, 2003). Compared to non-pregnant women, those that are pregnant have triple the likelihood of
developing severe malaria. Malaria during pregnancy poses signiﬁcant risks to the mother and fetus (Newal, 2009). Malariarelated complications in pregnant women include miscarriage, intrauterine growth disturbances, premature delivery, low birth
weight, hemorrhage, and neonatal transmission of malaria (Newal, 2009; Dombrowski et al., 2018; Ouédraogo et al., 2012). Pregnant women are more likely to be asymptomatic than their non-pregnant counterparts, increasing the potential for the progression of severe pregnancy outcomes in incognizant hosts (Khan et al., 2014). Malaria has been linked to more than 10,000
maternal and 200,000 neonatal fatalities annually. An estimated 25 million pregnant women are at risk for contracting malaria
worldwide (Newal, 2009).
Malaria remains a poverty-driven disease that is endemic in low and middle-income countries (LMIC) (Ren, 2019). While LMIC
carry the greatest burden of malaria, the disease was eradicated in the US in the 1940s following the implementation of public
health interventions such as dichlorodiphenyl-trichloroethane (DDT) spraying campaigns (Newal, 2009). In spite of these efforts,
2000 new cases of malaria occur in the US annually as a result of increased global trafﬁc from travel and immigration (Centers for
Disease Control and Prevention, 2020). Considering that women of childbearing age make up a considerable proportion of people
that travel to endemic regions, those that are pregnant are speciﬁcally advised against travelling to countries that pose risks of
malaria infection (Arguin et al., 2015; Pillay and Macdonald, 2012). In 2012, pregnant women made up 6% of travel-related
cases of malaria among women in the US (Arguin et al., 2015).
Several studies have examined gestational malaria, but few are speciﬁc to the US (Pillay and Macdonald, 2012; Perez et al.,
2016; Khuu et al., 2017). The reports that included data about pregnant women with malaria focused primarily on disease transmission and health complications (Khuu et al., 2017; Centers for Disease Control and Prevention, 2018). The most recent study in
the US to investigate trends in malaria-related maternal hospitalizations included data up until 2014 and disproportionately represented men (Khuu et al., 2017). Given that malaria also affects pregnant women and poses severe health outcomes, updated
information is required speciﬁc to this population (Newal, 2009; Dombrowski et al., 2018; Ouédraogo et al., 2012; Khan et al.,
2014). To the authors' knowledge, this is the ﬁrst national analysis of temporal trends of gestational malaria in the US.

2. Methods
We conducted a retrospective, cross-sectional analysis using the Nationwide Inpatient Sample (NIS) dataset covering the period from January 1, 2002 to December 31, 2017. This data was assembled from hospitals across the United States and managed
by the Agency for Healthcare Research and Quality (AHRQ). The NIS database utilized for this study is a robust sample of all payer,
publicly available database of inpatient hospitalizations in the country. The database contains an array of clinical and non-clinical
information including: urban/rural setting, hospital teaching status, race/ethnicity, and US Census Bureau geographic region etc.
We utilized International Classiﬁcation of Disease, Ninth revision, Clinical Modiﬁcation (ICD-9-CM) diagnosis and procedure
codes prior to October 1, 2015, and ICD 10-CM/PCS after that. Because the study was performed on de-identiﬁed, publicly available data, the Institutional Review Board (IRB) of Baylor College of Medicine deemed it as exempt.
We restricted the study sample to inpatient hospitalizations of pregnant adolescent and adult women, 15–49 years, who were
diagnosed with malaria. Malaria was coded using ICD-9-CM diagnoses codes beginning with ‘647.4’ and ‘084’ and ICD-10-CM diagnosis codes ‘B50’, ‘B51’, ‘B52’, ‘B53’and ‘B54’. As a secondary aim, we also examined ﬁve selected maternal-fetal outcomes: maternal anemia, poor fetal growth, stillbirth, severe preeclampsia and preterm labor. Anemia was coded using ICD-9 codes
beginning with ‘280’, ‘281’, ‘282’, ‘283’ ‘284’, ‘285’, ‘648.2’ and ICD-10 codes beginning with ‘D5’, ‘D60’, ‘D61’, ‘D62’, ‘D63’, ‘D64’,
‘O99.0’. Poor fetal growth was coded in ICD-9 format as ‘656.5’ and in ICD-10 format as ‘O36.59’. Stillbirth was coded using
ICD-9 diagnosis codes beginning with ‘656.4’, ‘V27.1’, ‘V27.3’, ‘V27.4’, ‘V27.6’, ‘V27.7’ and ICD-10 diagnosis codes beginning with
‘O36.4’, ‘Z37.1’, ‘Z37.3’, ‘Z37.4’, ‘Z37.6’ and ‘Z37.7’; severe preeclampsia was coded using ICD-9 diagnosis codes beginning with
‘642.5’ and ICD-10 codes beginning with ‘O14.1’; whereas preterm labor was identiﬁed using ICD-9-CM diagnosis codes beginning
with ‘644’ and ICD-10-CM codes beginning with ‘O60’. We conducted bivariate analyses to study the relationships between various patient socio-demographic and hospital characteristics versus prevalence of malaria.
Next, we created joinpoint regression models to estimate and describe the trends in the rates of gestational malaria over the
study period. Joinpoint regression is a modeling technique which is used to analyze the varying trends of an outcome over time
(National Cancer Institute, 2019). The iterative model-building process was initiated by ﬁtting the annual rate data to a straight
line with no joinpoints, which assumed a single trend best described the data. Then a joinpoint – reﬂecting a change in the
trend – was added to the model and a Monte Carlo simulation technique assessed the improvement in model ﬁt. The process continued until a ﬁnal model with an optimal (best-ﬁtting) number of joinpoints was selected, with each joinpoint indicating a
change in the trend, and an average annual percent change (AAPC) was then estimated to describe how the rate changed over
the entire study period.
Lastly, we restricted the data to pregnancy hospitalizations with a diagnosis of malaria. After removing missing information
from the covariates, survey logistic regression models were run to compute adjusted odds ratios for the association between
our selected socio-demographic features, hospital characteristics, and the selected outcomes for the study, namely, maternal anemia, poor fetal growth, stillbirth, severe preeclampsia and preterm labor. All tests of hypotheses were two-tailed with a type 1
error rate set at 5%. Data analyses were performed using R (version 3∙6∙1) and RStudio (Version 1∙1∙423).
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3. Results
We analyzed a total of 76,023,717 pregnancy hospitalizations from 2002 to 2017, of which 1761 had a diagnosis of malaria
corresponding to a rate of 2.3 per 100,000 pregnancy-related hospitalizations.
3.1. Socio-demographic factors
Table 1 shows the relationship between socio-demographic factors, hospital features, and comorbid characteristics among hospitalized pregnant women with or without malaria. There was a positive relationship between prevalence of malaria and maternal
age, with the highest prevalence observed among women aged 35–49 years. The prevalence of malaria was greatest among NHBlacks, while NH-White and Hispanic mothers experienced the lowest prevalence of the disease. Among pregnant women for
whom discharge status was known, those that were discharged against medical advice (DAMA) had the highest prevalence of
gestational malaria (6.54 per 100,000) followed by mothers that were transferred to other facilities (4.76 per 100,000).
Excluding hospitalized pregnant women with missing information on zip code income, mothers in the lowest income quartile
(0th to 25th percentile) accounted for the highest proportion of malaria. However, pregnant women in the highest income quartile (76th to 100th percentile) had the greatest prevalence of malaria (2.97 per 100,000). Among in-hospital pregnant women for
whom insurance status was known, those covered by Medicaid, and those that self-paid for medical services exhibited the highest
prevalence of gestational malaria. Pregnant women on private insurance experienced the lowest prevalence of diagnosed cases of
gestational malaria (0.98 per 100,000 pregnancy-related hospitalizations).
We found that hospitalized pregnant women in the Southern part of the US accounted for the largest proportion of malaria
cases, while those in the Midwest had the highest prevalence of the infection. Notably, there were no hospitalized pregnant
women in the West with malaria. Although the largest proportion of gestational malaria cases was diagnosed in urban teaching
hospitals (approximately 40% of the cases), the highest prevalence of gestational malaria was observed in rural hospital settings.
The prevalence of gestational malaria was very high (9.51 per 100,000 pregnancy hospitalization) among those with anemia
whereas the prevalence was similar among pregnancies complicated by stillbirth, severe preeclampsia, or preterm labor.
3.2. Temporal trends
Fig. 1 depicts the trends in malaria rates among hospitalized pregnant women over the study period using observed data and
joinpoint regression estimate overlays. The joinpoint regression estimator indicates that the average annual percent change
(AAPC) of malaria among pregnant women increased signiﬁcantly over the period by 5.7% (95% CI [0.7, 10.9]). From a baseline
of 2.15 per 100,000 in 2002, the rate of malaria infection among pregnant women climbed variably and peaked in 2016 at
5.01 per 100,000 hospitalizations.
3.3. Health complications associated with gestational malaria
Table 2 illustrates the association between various patient and hospital characteristics versus selected maternal-fetal outcomes
(anemia, poor fetal growth, stillbirth, severe preeclampsia, and preterm labor) among pregnancy-related hospitalizations. Mothers
diagnosed with gestational malaria were 5 times as likely (OR = 5.05, 95% CI: 4.05–6.29) to be anemic as compared to those
without malaria. The adjusted odds of other adverse events during pregnancy were similar for women with gestational malaria
and those without the diagnosis. Whereas advancing maternal age showed a positive association with stillbirth, maternal age
was negatively associated with preterm labor. Compared to NH-Whites, NH-Black mothers were almost twice as likely to experience anemia and stillbirth; had about 50% greater adjusted odds of severe preeclampsia, and about 30% elevated likelihood for
preterm labor. Although Hispanic mothers had slight to moderate risks for stillbirth and severe preeclampsia respectively, they
appeared to enjoy mild protection from preterm labor.
Maternal death was the strongest discharge status associated with stillbirth, (OR = 2.23; 95% CI [1.88, 2.64]) while transfer to
another facility showed the greatest association with severe preeclampsia (OR = 2.34; 95% CI [2.22,2.46]) and preterm labor
(OR = 2.90; 95% CI [2.78,3.03]). Higher zip code income was protective of anemia, poor fetal growth, stillbirth, preeclampsia,
and preterm labor. Compared to pregnant women under Medicare, those in other healthcare coverage categories exhibited higher
adjusted odds for poor fetal growth, adverse maternal-fetal outcomes. Regional differences were associated with anemia, stillbirth,
severe preeclampsia, and preterm labor. Compared to pregnant women in the Northeast, those in other regions experienced slight
to moderate higher odds of stillbirth and severe preeclampsia. We noted an inverse relationship between hospital size and adverse pregnancy outcomes with large hospital sizes exhibiting greater adjusted odds for the diagnoses of stillbirth, severe preeclampsia, and preterm labor. Compared to rural facilities, diagnoses of severe preeclampsia and preterm labor were highest in
urban hospitals. Hospitalizations associated with stillbirth were more likely in rural and urban teaching hospitals than in urban
non-teaching facilities.
4. Discussion
This population-based, nationally representative study investigated socio-demographic factors, temporal trends, and adverse
maternal-fetal outcomes among pregnant women with malaria in the US from 2002 to 2017. The most recent study to measure
3
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Table 1
Socio-demographic factors, hospital features, and comorbid characteristics among hospitalized pregnant women with or without malaria.
Malaria

Prevalence of malaria per 100,000
pregnancy hospitalizations

No
Patient characteristics
Age
15–24 years
25–34 years
35–49 years
Race
NH-Whitea
NH-Blacka
Hispanic
Other
Missing
Discharge status
Routine
Transfer
Died
DAMAb
Other
Missing
Zip income quartile
Lowest quartile
2nd quartile
3rd quartile
Highest quartile
Missing
Primary payer
Medicare
Medicaid
Private insurance
Self-pay
Other/Missing
Hospital characteristics
Hospital region
Northeast
Midwest
South
West
Hospital bed size
Small
Medium
Large
Missing
Hospital location and teaching status
Rural
Urban non-teaching
Urban teaching
Missing
Comorbidities
Anemia
No
Yes
Poor fetal growth
No
Yes
Stillbirth
No
Yes
Severe preeclampsia
No
Yes
Preterm labor
No
Yes
a
b

Yes

n
23,789,034
38,016,592
14,216,330

%
31.3%
50.0%
18.7%

n
421
784
556

%
23.9%
44.5%
31.6%

1.77
2.06
3.91

33,710,143
9,983,809
14,088,849
6,624,668
11,614,487

44.3%
13.1%
18.5%
8.7%
15.3%

299
931
111
235
184

17.0%
52.9%
6.3%
13.3%
10.4%

0.89
9.32
0.79
3.55
1.58

72,897,529
819,260
57,278
381,951
1,844,844
21,093

95.9%
1.1%
0.1%
0.5%
2.4%
0.0%

1681
39
0
25
15
0

95.5%
2.2%
0.0%
1.4%
0.9%
0.0%

2.31
4.76
0.00
6.54
0.81
0.00

16,532,293
14,421,506
13,781,102
12,211,700
19,075,354

21.7%
19.0%
18.1%
16.1%
25.1%

379
333
312
363
373

21.5%
18.9%
17.7%
20.6%
21.2%

2.29
2.31
2.26
2.97
1.96

3,550,930
25,614,441
30,450,644
3,807,596
12,598,345

4.7%
33.7%
40.1%
5.0%
16.6%

232
485
299
246
499

13.2%
27.5%
17.0%
14.0%
28.3%

6.53
1.89
0.98
6.46
3.96

9,889,580
20,895,553
44,992,786
244,036

13.0%
27.5%
59.2%
0.3%

253
550
958
0

14.4%
31.2%
54.4%
0.0%

2.56
2.63
2.13
0.00

8,059,262
27,503,543
40,215,115
244,036

10.6%
36.2%
52.9%
0.3%

30
376
1354
0

1.7%
21.4%
76.9%
0.0%

0.37
1.37
3.37
0.00

12,613,168
16,173,251
29,145,471
18,090,065

16.6%
21.3%
38.3%
23.8%

527
264
699
270

29.9%
15.0%
39.7%
15.3%

4.18
1.63
2.40
1.49

66,797,567
9,224,388

87.9%
12.1%

883
877

50.1%
49.8%

1.32
9.51

74,523,365
1,498,591

98.0%
2.0%

1746
14

99.1%
0.8%

2.34
0.93

75,571,405
450,551

99.4%
0.6%

1749
11

99.3%
0.6%

2.31
2.44

75,070,697
951,258

98.7%
1.3%

1736
24

98.6%
1.4%

2.31
2.52

70,371,196
5,650,760

92.6%
7.4%

1629
131

92.5%
7.4%

2.31
2.32

NH stands for Non-Hispanic.
DAMA stands for Discharged Against Medical Advice.
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Fig. 1. Trends in rates of malaria per 100,000 maternal hospitalizations from 2002 to 2017.

trends in malaria hospitalizations nationwide analyzed data up until 2014 and largely overrepresented men (Khuu et al., 2017).
Our ﬁndings show that hospitalizations among pregnant women with malaria peaked in 2016 at 5.01 per 100,000, underscoring
the necessity for updated data. To the authors' knowledge, this is the ﬁrst national analysis of temporal trends among pregnant
women living with malaria in the US. During the 15-year period of the study, AAPC signiﬁcantly increased by 5.7% among hospitalized pregnant women with malaria. These results are consistent with a previous study that found a positive trend in hospitalizations among patients with malaria in the US (Khuu et al., 2017). This increasing trend may be the result of greater global trafﬁc
(Spencer et al., 2010).
Although the prevalence of malaria in the US is low as compared to endemic countries, maternal hospitalizations for malaria
are not atypical in the US (Centers for Disease Control and Prevention, 2019b). Contrary to our expectation, we found that there
was no association between malaria and stillbirth, severe preeclampsia and preterm labor. The eradication of malaria from the US
in the 1940s could explain this ﬁnding because low and high transmission settings present with unique clinical outcomes (Howes
et al., 2016; Centers for Disease Control and Prevention, 2015). Moreover, there may be an association between gestational malaria and other adverse pregnancy outcomes not included in the scope of this study but have been found to be signiﬁcantly associated with gestational malaria in other reports (Newal, 2009; Dombrowski et al., 2018; Ouédraogo et al., 2012; Khan et al., 2014).
Further research is needed to consider the effect of gestational malaria on additional pregnancy complications in the US.
Although the adjusted odds of adverse events were similar among women with and without gestational malaria, these outcomes were uniquely associated with various sociodemographic factors and hospital characteristics. Among in-hospital pregnant
women, Black women aged 35–49 years experienced greater prevalence rates of malaria. These results somewhat agree with the
literature which found that hospitalized, Black patients aged 45–64 years had the greatest prevalence of malaria (Khuu et al.,
2017). We also found that pregnant women designated as “DAMA” were nearly three times as likely to have malaria, and had
over twice the adjusted odds of stillbirth compared to those that were routinely discharged. The signiﬁcant burden of a lack of
stable social support systems, substance abuse co-morbidity and low-income status frequently experienced by patients that
leave AMA may explain the elevated risk for gestational malaria as well as malaria-associated pregnancy complications (Paul
et al., 2019; Glasgow et al., 2010). DAMA has also been linked to deleterious feto‑neonatal outcomes such as respiratory distress,
low birth weight and fetal death.
Compared to pregnant women with malaria under Medicare, those who self-paid for healthcare coverage were more likely to
experience stillbirth, severe preeclampsia and preterm labor. Patients that self-pay for medical services are more likely to be lowincome (Becker and Newsom, 2003). We also observed an inverse relationship between income level and the likelihood for the
ﬁve adverse outcomes. Pregnant women in the highest income quartile experienced the fewest complications. The information
available in the data was at hospital discharge level and not patient level. Furthermore, it was not possible to track a patient
over time due to the cross-sectional nature of the dataset. Therefore, we were not able to identify the point in pregnancy at
which the malaria diagnosis was made. Additionally, information on travel history of mothers diagnosed with gestational malaria,
management of the disease or follow-up tests to verify effectiveness/response to the treatment was not available in the dataset.
Additional information that was absent from the data we analyzed but would have likely impacted our analysis included types of
5
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Table 2
Adjusted survey binomial logistic regression model to assess the association between various malaria and maternal-fetal outcomes among pregnant women.

Malaria
No
Yes
Patient characteristics
Age
15–24 years
25–34 years
35–49 years
Race
NH-White
NH-Black
Hispanic
Other
Discharge status
Routine
Transfer
Died
DAMA
Other
Missing
Zip income quartile
Lowest quartile
2nd quartile
3rd quartile
Highest quartile
Primary payer
Medicare
Medicaid
Private Insurance
Self Pay

Anemia

Poor fetal growth

Stillbirth

Severe Preeclampsia

Preterm Labor

OR(95%CI)

OR(95%CI)

OR(95%CI)

OR(95%CI)

OR(95%CI)

reference
5.05(4.05–6.29)

0.37(0.12–1.14)

0.80(0.20–3.18)

0.91(0.38–2.18)

0.96(0.65–1.42)

reference
0.87(0.86–0.88)
1.03(1.01–1.04)

0.76(0.76–0.77)
0.62(0.61–0.64)

1.03(1.01–1.04)
1.21(1.18–1.23)

0.89(0.88–0.91)
0.89(0.87–0.91)

0.88(0.87–0.88)
0.82(0.81–0.84)

reference
2.09(2.04–2.14)
1.23(1.17–1.3)
1.29(1.24–1.34)

1.22(1.19–1.25)
0.69(0.66–0.72)
1.18(1.14–1.21)

1.82(1.78–1.87)
1.05(1.02–1.08)
1.09(1.06–1.13)

1.47(1.43–1.52)
1.18(1.10–1.26)
1.01(0.97–1.04)

1.27(1.24–1.30)
0.94(0.91–0.97)
0.96(0.94–0.99)

reference
1.37(1.34–1.4)
2.06(1.96–2.16)
1.11(1.08–1.14)
1.57(1.50–1.65)

0.67(0.64–0.71)
0.12(0.08–0.18)
0.73(0.67–0.78)
0.91(0.85–0.97)

0.64(0.59–0.7)
2.23(1.88–2.64)
1.19(1.09–1.30)
0.37(0.34–0.42)

2.34(2.22–2.46)
1.00(0.84–1.18)
1.03(0.96–1.11)
1.34(1.23–1.46)

2.9(2.78–3.03)
0.35(0.3–0.41)
1.83(1.76–1.91)
0.70(0.66–0.73)

reference
0.95(0.93–0.97)
0.93(0.90–0.95)
0.83(0.79–0.86)

1.00(0.98–1.02)
0.98(0.95–1.00)
0.98(0.95–1.02)

0.95(0.93–0.97)
0.91(0.89–0.93)
0.79(0.77–0.81)

0.98(0.96–1.00)
0.96(0.93–0.98)
0.88(0.84–0.91)

0.95(0.94–0.97)
0.91(0.89–0.93)
0.89(0.86–0.91)

reference
0.73(0.70–0.76)
0.56(0.54–0.58)
0.66(0.62–0.7)

1.60(1.54–1.66)
1.48(1.43–1.53)
1.28(1.21–1.35)

1.37(1.31–1.42)
1.22(1.17–1.27)
1.72(1.64–1.81)

1.59(1.51–1.68)
1.66(1.60–1.73)
1.53(1.44–1.63)

2.19(2.12–2.25)
1.96(1.90–2.01)
2.09(2.00–2.18)

1.01(0.95–1.06)
1.11(1.05–1.18)
0.98(0.92–1.04)

1.06(1.01–1.10)
1.16(1.12–1.20)
1.08(1.04–1.13)

1.10(1.03–1.16)
1.28(1.20–1.37)
1.13(1.06–1.19)

0.99(0.94–1.05)
1.12(1.06–1.18)
1.09(1.03–1.16)

1.06(1.01–1.12)
1.2(1.14–1.26)

1.08(1.05–1.12)
1.17(1.14–1.21)

1.22(1.16–1.29)
1.49(1.41–1.57)

1.21(1.13–1.28)
1.43(1.35–1.51)

1.08(1.02–1.13)
1.35(1.28–1.42)

0.93(0.90–0.96)
1.10(1.07–1.14)

1.20(1.14–1.26)
2.13(2.00–2.26)

1.15(1.1–1.21)
1.59(1.51–1.68)

Hospital characteristics
Hospital region
Northeast
reference
Midwest
1.16(1.09–1.23)
South
1.19(1.11–1.27)
West
1.14(1.06–1.22)
Hospital bed size
Small
reference
Medium
0.92(0.87–0.97)
Large
0.93(0.88–0.98)
Hospital location and teaching status
Rural
reference
Urban non-teaching
0.88(0.83–0.94)
Urban teaching
1.16(1.08–1.23)

treatment received and the species of the infecting agent. Future studies with more in-depth clinical information should also include considerations of patient-level data such as travel history and immigration status that are otherwise not available in the NIS
database (Khuu et al., 2017).
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